Aerosol delivery of urocanic acid-modified chitosan/programmed cell death 4 complex regulated apoptosis, cell cycle, and angiogenesis in lungs of K-ras null mice

Molecular Cancer Therapeutics

Volumn 5, Issue 4, 2006, Pages 1041-1049

  Jin, Hua ^a   Tae, Hee Kim ^b   Hwang, Soon Kyung ^a   Chang, Seung Hee ^a   Hyun, Woo Kim ^a   Anderson, Hanjo K ^a   Lee, Han Woong ^d   Lee, Kee Ho ^c   Colburn, Nancy H ^e   Yang, Hsin Sheng ^f   Cho, Myung Haing ^a,b   Chong, Su Cho ^b  

^a Konkuk University   (South Korea)

^b Seoul National University   (South Korea)

^c Korea Institute of Radiation and Medical Science   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

^e NATIONAL CANCER INSTITUTE   (United States)

^f UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; PROGRAMMED CELL DEATH 4; UNCLASSIFIED DRUG; UROCANIC ACID; UROCANIC ACID MODIFIED CHITOSAN;

AEROSOL; ANGIOGENESIS; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG INHIBITION; GENE TARGETING; LUNG CANCER; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL CYCLE; CELL SURVIVAL; CHITOSAN; GENES, RAS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED ICR; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; RNA-BINDING PROTEINS; UROCANIC ACID;

EID: 33646538780     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-05-0433     Document Type: Article

References (34)

1. Ahn CH, Chae SY, Bae YH, Kim SW. Biodegradable poly(ethylenimine) for plasmid DNA delivery. J Control Release 2002;80:273-82.
2. Bellon G, Michel-Calemard L, Thouvenot D, et al. Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: a phase I clinical trial. Hum Gene Ther 1997;8:15-25.
3. Crystal RG, McElvaney NG, Rosenfeld MA, et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet 1994;8:42-51.
4. Zabner J, Ramsey BW, Meeker DP, et al. Repeated administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. J Clin Invest 1996;97:1504-11.
5. Harvey BG, Leopold PL, Hackett NR, et al. Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus. J Clin Invest 1999;104:1245-55.
6. Kim HW, Park IK, Cho CS, et al. Aerosol delivery of glucosylated polyethylenimine/phosphatase and tensin homologue deleted on chromosome 10 complex suppresses Akt downstream pathways in the lung of K-ras null mice. Cancer Res 2004;64:7971-6.
7. Mao HQ, Roy K, Troung-Le VL, et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release 2001;70:399-421.
8. Schwartz B, Ivanov MA, Pitard B, et al. Synthetic DNA-compacting peptides derived from human sequence enhance cationic lipid-mediated gene transfer in vitro and in vivo. Gene Ther 1999;6:282-92.
9. Wang J, Zhang PC, Lu HF, et al. New polyphosphoramidate with a spermidine side chain as a gene carrier. J Control Release 2002;83: 157-68.
10. Thomas M, Klibanov AM. Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells. Proc Natl Acad Sci U S A 2002;99:14640-5.
11. Zabner J, Fasbender AJ, Moninger T, Poellinger KA, Welsh MJ. Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem 1995;270:18997-9007.
12. Segura T, Shea LD. Materials for non-viral gene delivery. Annu Rev Mater Res 2001;31:25-46.
13. Lee KY, Kwon IC, Kim YH, Jo WH, Jeong SY. Preparation of chitosan self-aggregates as a gene delivery system. J Control Release 1998;51: 213-20.
14. Köping-Höggård M, Tubulekas I, Guan H, et al. Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther 2001;8:1108-21.
15. Kim TH, Ihm JE, Choi YJ, Nah JW, Cho CS. Efficient gene delivery by urocanic acid-modified chitosan. J Control Release 2003;93:389-40.
16. Pellegata NS, Antoniono RJ, Redpath JL, Stanbridge EJ. DNA damage and p53-mediated cell cycle arrest: a reevaluation. Proc Natl Acad Sci U S A 1996;93:15209-14.
17. Johnson L, Mercer K, Greenbaum D, et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 2001;410: 1111-6.
18. Jansen AP, Camalier CE, Colburn NH. Epidermal expression of the translation inhibitor programmed cell 20 death 4 suppresses tumorigenesis. Cancer Res 2005;65:6034-41.
19. Yang HS, Jansen AP, Nair R, et al. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene 2001;20:669-76.
20. Jang MK, Jeong YI, Cho CS, Yang SH, Kang YE, Nah JW. The preparation and characterization of low molecular and water soluble free-amine chitosan. Bull Korean Chem Soc 2002;23:914-6.
21. Goke R, Barth P, Schmidt A, Samans B, Lankat-Buttgereit B. Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1). Am J Physiol Cell Physiol 2004;287:C1541-6.
22. Post MJ, Laham R, Sellke FW, Simons M. Therapeutic angiogenesis in cardiology using protein formulations. Cardiovasc Res 2001;49: 522-31.
23. Park MR, Han KO, Han IK, et al. Degradable polyethylenimine-alt- poly(ethylene glycol) copolymers as novel gene carriers. J Control Release 2005;105:367-80.
24. Jiang HL, Park IK, Shin NR, Yoo HS, Akaike T, Cho CS. Controlled release of Bordetella bronchiseptica dermonecrotoxin (BBD) vaccine from BBD-loaded chitosan microspheres in vitro. Arch Pharm Res 2004; 27:346-50.
25. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309-12.
26. Afonja O, Juste D, Das S, Matsuhashi S, Samuels HH. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Oncogene 2004; 23:8135-45.
27. Ikuta K, Takemura K, Kihara M, et al. Defects in apoptotic signal transduction in cisplatin-resistant nonsmall cell lung cancer cells. Oncol Rep 2005;13:1229-34.
28. Hurbin A, Coll JL, Dubrez-Daloz L, et al. Cooperation of amphiregulin and insulin-like growth factor-1 inhibits Bax- and Bad-mediated apoptosis via a protein kinase C-dependent pathway in non-small cell lung cancer cells. J Biol Chem 2005;280:19757-67.
29. Takimoto H, Hasegawa M, Yagi K, Nakamura T, Sakeda T, Hirai M. Proapoptotic effect of a dietary supplement: water soluble chitosan activates caspase-8 and modulating death receptor expression. Eur J Drug Metab Pharmacokinet 2004;19:76-82.
30. Caputi M, Russo G, Esposito V, Mancini A, Giordano A. Role of cell-cycle regulators in lung cancer. J Cell Physiol 2005;205:319-27.
31. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
32. Bergsland EK. Vascular endothelial growth factor as a therapeutic target in cancer. Am J Health Syst Pharm 2004;61:S4-11.
33. Sandler AB, Johnson DH, Herbst RS. Anti-vascular endothelial growth factor monoclonals in non-small cell lung cancer. Clin Cancer Res 2004; 10:4258-62.
34. Cox G, Jones JL, Walker RA, Steward WP, O'Bryne KJ. Angiogenesis and non-small cell lung cancer. Lung Cancer 2000;27:81-100.